Integration of Alzheimer's disease genetics and myeloid genomics identifies disease risk regulatory elements and genes.
Level 5 - mechanism / opinion, no new human data
Mechanistic computational genomics and in vitro cell model validation (Level 5 by design analogy)
PubMed 33712570 · doi:10.1038/s41467-021-21823-y
What was done
Researchers integrated Alzheimer's disease (AD) genome-wide association study (GWAS) data with myeloid epigenomic and transcriptomic datasets from monocytes, macrophages, and microglia. Using analytical fine-mapping and integration methods, they linked myeloid enhancer activity to target gene expression and AD risk modification, and experimentally tested a candidate variant at the MS4A locus in human induced pluripotent stem cell (hiPSC)-derived microglia and brain tissue.
What was found
AD risk alleles were enriched specifically in active enhancers of monocytes, macrophages, and microglia. The authors mapped AD risk enhancers and nominated candidate causal target genes across 20 loci (including AP4E1, AP4M1, APBB3, BIN1, MS4A4A, MS4A6A, PILRA, RABEP1, SPI1, TP53INP1, and ZYX). A single candidate functional variant in the MS4A locus was identified and validated. The abstract reports no numerical metrics, effect sizes, or p-values.
Why it matters
The study maps non-coding Alzheimer's risk variants to specific myeloid enhancers and target genes, providing mechanistic candidates for how immune cell gene regulation influences disease susceptibility.
Limits
Sample sizes, donor counts, and quantitative metrics are omitted from the abstract. Most candidate regulatory elements and target genes remain computational nominations without experimental validation beyond the single MS4A locus. In vitro stem-cell-derived microglia may not fully capture in vivo human brain pathogenesis.
Cited by
- supports The common non-monogenic genetic risk factors for Alzheimer's disease overwhelmingly map to genomic regions that regulate gene expression selectively in microglia rather than in neurons or other brain cell types.